Cypherpunk Technologies Inc. (CYPH) vs Orchestra BioMed Holdings, Inc. (OBIO)

Cypherpunk Technologies Inc. and Orchestra BioMed Holdings, Inc. are both Biotechnology companies. Cypherpunk Technologies Inc. and Orchestra BioMed Holdings, Inc. are of similar size ($345.0M and $325.5M). Orchestra BioMed Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Cypherpunk Technologies Inc. trades at 4.4×. Orchestra BioMed Holdings, Inc. grew revenue faster over the last twelve months: 986.1% against 0.00%. Cypherpunk Technologies Inc. has the higher net margin (0.00% vs −186.3%) and the lower return on invested capital (−8.44% vs 0.00%). Across the 17 metrics below, Cypherpunk Technologies Inc. leads on 12 and Orchestra BioMed Holdings, Inc. on 5.

Valuation

Metric CYPH OBIO Biotechnology median
P/E 4.36 n/m 8.50
P/S 315.82 10.88 9.71
P/B 3.40 18.00 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 310.73 8.53 9.21
Earnings yield 22.96% (15.60%) (33.15%)
Free cash flow yield (4.44%) (16.99%) (25.50%)

Profitability

Metric CYPH OBIO Biotechnology median
Gross margin 0.00% 99.51% 65.16%
Operating margin 0.00% (181.36%) 0.00%
Net margin 0.00% (186.30%) 0.00%
Free cash flow margin 0.00% (184.83%) 0.00%
Return on equity (1.21%) (607.32%) (56.36%)
Return on assets (1.08%) (75.16%) (48.04%)
Return on invested capital (8.44%) 0.00% 0.00%

Growth

Metric CYPH OBIO Biotechnology median
Revenue growth (TTM) 0.00% 986.14% 6.02%
EPS growth (last fiscal year) 103.87% 33.13% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYPH OBIO Biotechnology median
Debt to equity 0.00 1.80 0.00
Current ratio 79.19 8.26 4.72
Net debt to EBITDA 0.34 1.80 0.96

Dividend

Metric CYPH OBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CYPH OBIO Biotechnology median
Market cap 325.45m 345.00m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack